Trial intelligence / Profile preview

RTS,S/AS01 Efficacy Against Malaria in Children

NCT00380393Phase 2Completed

Sponsor
GSK
Start
Jan 2007
Primary completion
Aug 2008
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

Phase 2, randomised, double-blind trial of RTS,S in Plasmodium falciparum malaria (2 arms), sponsored by GSK. Primary endpoint: Frequency of First Case of Malaria Meeting the Primary Case Definition. Started Jan 2007; status: completed.

02

Drugs

RTS,S
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT00380393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00380393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call